These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 32601768

  • 1. Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels.
    Baker MD, Nassar MA.
    Pflugers Arch; 2020 Jul; 472(7):865-880. PubMed ID: 32601768
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Painful and painless channelopathies.
    Bennett DL, Woods CG.
    Lancet Neurol; 2014 Jun; 13(6):587-99. PubMed ID: 24813307
    [Abstract] [Full Text] [Related]

  • 4. [Pain and analgesia : Mutations of voltage-gated sodium channels].
    Eberhardt MJ, Leffler A.
    Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.
    Huang J, Han C, Estacion M, Vasylyev D, Hoeijmakers JG, Gerrits MM, Tyrrell L, Lauria G, Faber CG, Dib-Hajj SD, Merkies IS, Waxman SG, PROPANE Study Group.
    Brain; 2014 Jun; 137(Pt 6):1627-42. PubMed ID: 24776970
    [Abstract] [Full Text] [Related]

  • 7. Gain-of-function mutations in SCN11A cause familial episodic pain.
    Zhang XY, Wen J, Yang W, Wang C, Gao L, Zheng LH, Wang T, Ran K, Li Y, Li X, Xu M, Luo J, Feng S, Ma X, Ma H, Chai Z, Zhou Z, Yao J, Zhang X, Liu JY.
    Am J Hum Genet; 2013 Nov 07; 93(5):957-66. PubMed ID: 24207120
    [Abstract] [Full Text] [Related]

  • 8. The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.
    Han C, Vasylyev D, Macala LJ, Gerrits MM, Hoeijmakers JG, Bekelaar KJ, Dib-Hajj SD, Faber CG, Merkies IS, Waxman SG.
    J Neurol Neurosurg Psychiatry; 2014 May 07; 85(5):499-505. PubMed ID: 24006052
    [Abstract] [Full Text] [Related]

  • 9. Nav1.7 gain-of-function mutation I228M triggers age-dependent nociceptive insensitivity and C-LTMR dysregulation.
    Wimalasena NK, Taub DG, Shim J, Hakim S, Kawaguchi R, Chen L, El-Rifai M, Geschwind DH, Dib-Hajj SD, Waxman SG, Woolf CJ.
    Exp Neurol; 2023 Jun 07; 364():114393. PubMed ID: 37003485
    [Abstract] [Full Text] [Related]

  • 10. Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.
    Kamei T, Kudo T, Yamane H, Ishibashi F, Takada Y, Honda S, Maezawa Y, Ikeda K, Oyamada Y.
    Biochem Biophys Res Commun; 2024 Aug 20; 721():150126. PubMed ID: 38776832
    [Abstract] [Full Text] [Related]

  • 11. Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.
    Xue Y, Chidiac C, Herault Y, Gaveriaux-Ruff C.
    Neurosci Lett; 2021 May 14; 753():135844. PubMed ID: 33775738
    [Abstract] [Full Text] [Related]

  • 12. The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy.
    Han C, Themistocleous AC, Estacion M, Dib-Hajj FB, Blesneac I, Macala L, Fratter C, Bennett DL, Waxman SG, Dib-Hajj SD.
    Mol Pharmacol; 2018 Nov 14; 94(5):1256-1269. PubMed ID: 30135145
    [Abstract] [Full Text] [Related]

  • 13. Atypical changes in DRG neuron excitability and complex pain phenotype associated with a Nav1.7 mutation that massively hyperpolarizes activation.
    Huang J, Mis MA, Tanaka B, Adi T, Estacion M, Liu S, Walker S, Dib-Hajj SD, Waxman SG.
    Sci Rep; 2018 Jan 29; 8(1):1811. PubMed ID: 29379075
    [Abstract] [Full Text] [Related]

  • 14. A novel gain-of-function Nav1.7 mutation in a carbamazepine-responsive patient with adult-onset painful peripheral neuropathy.
    Adi T, Estacion M, Schulman BR, Vernino S, Dib-Hajj SD, Waxman SG.
    Mol Pain; 2018 Jan 29; 14():1744806918815007. PubMed ID: 30392441
    [Abstract] [Full Text] [Related]

  • 15. Characterisation of Nav1.7 functional expression in rat dorsal root ganglia neurons by using an electrical field stimulation assay.
    Fouillet A, Watson JF, Piekarz AD, Huang X, Li B, Priest B, Nisenbaum E, Sher E, Ursu D.
    Mol Pain; 2017 Jan 29; 13():1744806917745179. PubMed ID: 29166836
    [Abstract] [Full Text] [Related]

  • 16. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
    Shields SD, Deng L, Reese RM, Dourado M, Tao J, Foreman O, Chang JH, Hackos DH.
    J Neurosci; 2018 Nov 21; 38(47):10180-10201. PubMed ID: 30301756
    [Abstract] [Full Text] [Related]

  • 17. Diversity of composition and function of sodium channels in peripheral sensory neurons.
    Dib-Hajj SD, Waxman SG.
    Pain; 2015 Dec 21; 156(12):2406-7. PubMed ID: 26580678
    [No Abstract] [Full Text] [Related]

  • 18. Differential effect of D623N variant and wild-type Na(v)1.7 sodium channels on resting potential and interspike membrane potential of dorsal root ganglion neurons.
    Ahn HS, Vasylyev DV, Estacion M, Macala LJ, Shah P, Faber CG, Merkies IS, Dib-Hajj SD, Waxman SG.
    Brain Res; 2013 Sep 05; 1529():165-77. PubMed ID: 23850641
    [Abstract] [Full Text] [Related]

  • 19. Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn.
    Black JA, Frézel N, Dib-Hajj SD, Waxman SG.
    Mol Pain; 2012 Nov 07; 8():82. PubMed ID: 23134641
    [Abstract] [Full Text] [Related]

  • 20. Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics.
    Chew LA, Bellampalli SS, Dustrude ET, Khanna R.
    Biochem Pharmacol; 2019 May 07; 163():9-20. PubMed ID: 30699328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.